Gilsbar to License Elsevier / MEDai's Risk Navigator Clinical® to Identify and Manage High Risk Populations and Improve Patient Care Quality
ORLANDO, Florida, January 17, 2012 /PRNewswire/ --
Elsevier / MEDai, the leader in predictive clinical analytic solutions, today announced Gilsbar, Inc. has licensed MEDai's Risk Navigator Clinical to proactively use analytics to provide value to their clients by identifying programs that will provide a return on investment for their constituents. Further they will support Care Management through the identification and management of high-risk members.
"With Elsevier / MEDai's Risk Navigator Clinical, our clients will be able to measure and monitor compliance to evidence-based guidelines and provide information to employers regarding population and group management," said Douglas Layman, Executive Vice President & CSMO, Gilsbar. "As more and more payers focus on gaining efficiencies and improving quality, the predictive modeling enabled by Risk Navigator Clinical will help our clients turn their data into actionable information so they can achieve both."
Gilsbar, based in Covington, LA., is one of the nation's fastest growing, private health and benefit management organizations. Gilsbar's three divisions - including Health & Benefit Management, MedCom Care Management and MedCom Care Advocates - provide proven methodologies to help keep members healthy and curb healthcare spend. Gilsbar's clients include benefit advisors, employers, associations, affinity groups, and insurance carriers.
"As Gilsbar supports its clients utilizing Risk Navigator Clinical, it can look forward to having a greater ability to identify and manage high risk populations utilizing claims and biometric data and ultimately improve the health status of their clients' employees and families," said Tom Zajac, President, Elsevier / MEDai. "Risk Navigator Clinical is the only predictive tool that gives payers a true 360-degree view of their member populations."
Gilsbar also plans to use Risk Navigator Clinical with its clients to conduct group reporting, provide feedback to employer groups and incorporate risk scores into actuarial models.
"Risk Navigator Clinical will help Gilsbar to proactively select at-risk individuals for interventions more effectively than before and will improve their support of wellness programs," said Hank Miltenberger, President and CEO of Gilsbar. "These programs will provide a demonstrated return on investment for our clients and improve the overall health of their members."
For more information about MEDai's Risk Navigator Clinical, please go to http://www.medai.com.
About Elsevier / MEDai
Elsevier / MEDai, Inc. is a leading health information company offering award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payers and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time, and improve outcomes. For more information on Elsevier / MEDai, visit http://www.medai.com. Its parent company, Elsevier, is a world-leading provider of scientific, technical and medical information products and services, with more than 7,000 employees in over 70 offices across 24 countries.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
About Gilsbar
Gilsbar® is one of the fastest growing, privately-held health and benefit management organizations in the country. Its divisions include TPA Services, MedCom Care Management, and Care Advocates. The Gilsbar group of companies is committed to improving the health and well-being of the clients they serve. They work with employers, benefit consultants, associations, carriers, and individuals nationwide. Gilsbar has been honored by Inc. magazine for its sustained growth and by Modern Healthcare and Business Insurance magazines as a Best Place to Work. For more information, visit http://www.gilsbar.com.
Media contact
Tom Reller
Vice President, Global Corporate Relations, Elsevier
+1-215-239-3508
[email protected]
SOURCE Elsevier
Share this article